HALEOS LABS LIMITED Share Price & Analysis
Price Chart
Fundamentals
Strengths
- Attractively valued vs sector (P/E 27.8x vs industry 54.7x)
- Low debt relative to equity (D/E 0.3x)
Concerns
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,899 | ₹4.6L Cr | 36.1 | 5.46 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹9,100 | ₹2.4L Cr | 81.1 | 14.42 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,857 | ₹1.8L Cr | 82.8 | 19.58 | 27.4 | 15.2 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,650 | ₹1.2L Cr | 59.1 | 13.13 | 21.2 | 17.4 | 0.88 |
| CIPLA Cipla Limited | ₹1,385 | ₹1.1L Cr | 31.3 | 3.25 | 11.6 | 15.5 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,120 | ₹1.1L Cr | 23 | 4.16 | 21.2 | 21.1 | 0.38 |
| LAURUSLABS Laurus Labs Limited | ₹1,840 | ₹99K Cr | 90.9 | 18.74 | 18.3 | 17.8 | 0.46 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
HALEOSLABS · as of Mar 2026
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 70.68% | 71.19% | 71.40% | 71.40% | 71.40% | 71.40% |
| FII | — | — | 0.01% | 0.02% | — | — |
| Public | 29.31% | 28.81% | 28.59% | 28.57% | 28.59% | 28.60% |
Latest News
All newsHaleos Labs reports Q1FY26 financial results
*Haleos Labs reports Q1FY26 financial results*. The company has submitted its financial performance for the quarter ended June 30, 2026. Results include key metrics like revenue and net profit, which will impact near-term price action. Traders should analyze the numbers for any deviation from estimates. 📊 *STOCKS:* $HALEOSLAB | 🏢 *SECTOR:* Pharma | #MEDIUMIMPACT #Earnings
Haleos Labs shares voting results announced via postal ballot
*Haleos Labs shares voting results announced via postal ballot.* The company has submitted the scrutinizers report on the postal ballot to the stock exchange. Shareholders' voting outcomes have been disclosed, though no material corporate action was specified. Details remain limited to procedural compliance. 📊 *STOCKS:* $HALEONLAB | 🏢 *SECTOR:* Pharma | #LOWIMPACT #CorporateAction
Haleos Labs issues TDS-related communication to shareholders
*Haleos Labs issues TDS-related communication to shareholders*. The company has shared a shareholder update concerning TDS matters. While no financial impact is indicated, it clarifies tax-related compliance. Such communications are routine and informational. 📊 *STOCKS:* $HALEON | 🏢 *SECTOR:* Pharma | #LOWIMPACT #TDS
Haleos Labs issues postal ballot notice via newspaper
*Haleos Labs issues postal ballot notice via newspaper.* A copy of a newspaper publication related to a postal ballot has been filed. This is a routine corporate disclosure under regulatory norms. No financial impact is indicated at this stage. 📊 *STOCKS:* $HALEONLAB | 🏢 *SECTOR:* Pharma | #LOWIMPACT #CorporateAction
About HALEOS LABS LIMITED
Incorporated in 2006, SMS Lifesciences Ltd is in the business of manufacturing of Active Pharma Ingredients and their intermediates[1]
HealthcarePharmaceuticals & Biotechnology